Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SYS6063
- Development stage
- Unknown
- Lead developer
- CSPC Pharmaceutical Group
- Modality
- Gene Addition/Replacement → Gene Therapies, Gene Silencing → Gene Therapies, Gene Editing → Gene Therapies, CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies
- Administration
- Intravenous
01
Overview
SYS6063 is an autologous, dual-targeting chimeric antigen receptor T-cell (CAR-T) therapy directed against CD19 and B-cell maturation antigen (BCMA). Developed by CSPC Pharmaceutical Group (specifically its subsidiary CSPC Zhongqi Pharmaceutical Technology), SYS6063 is designed to treat autoimmune disorders by inducing deep and durable depletion of the B-cell lineage, including both mature B cells and long-lived plasma cells. The therapy is currently under investigation in a Phase 1 clinical trial for patients with relapsed or refractory systemic lupus erythematosus (SLE) who have failed standard-of-care treatments, including biologic therapies.
- Other names
- anti-CD19/BCMA CAR-T
02
Targets
BCMA (B-cell maturation antigen)CD19 (B lymphocyte antigen CD19)
Beyond the preview
Go deeper on SYS6063.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SYS6063.